<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32070418</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1868-7083</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>18</Day></PubDate></JournalIssue><Title>Clinical epigenetics</Title><ISOAbbreviation>Clin Epigenetics</ISOAbbreviation></Journal><ArticleTitle>Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice.</ArticleTitle><Pagination><StartPage>32</StartPage><MedlinePgn>32</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">32</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13148-020-0816-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hexanucleotide repeat expansions of the G<sub>4</sub>C<sub>2</sub> motif in a non-coding region of the C9ORF72 gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Tissues from C9ALS/FTD patients and from mouse models of ALS show RNA foci, dipeptide-repeat proteins, and notably, widespread alterations in the transcriptome. Epigenetic processes regulate gene expression without changing DNA sequences and therefore could account for the altered transcriptome profiles in C9ALS/FTD; here, we explore whether the critical repressive marks H3K9me2 and H3K9me3 are altered in a recently developed C9ALS/FTD BAC mouse model (C9BAC).</AbstractText><AbstractText Label="RESULTS">Chromocenters that constitute pericentric constitutive heterochromatin were visualized as DAPI- or Nucblue-dense foci in nuclei. Cultured C9BAC astrocytes exhibited a reduced staining signal for H3K9me3 (but not for H3K9me2) at chromocenters that was accompanied by a marked decline in the global nuclear level of this mark. Similar depletion of H3K9me3 at chromocenters was detected in astrocytes and neurons of the spinal cord, motor cortex, and hippocampus of C9BAC mice. The alterations of H3K9me3 in the hippocampus of C9BAC mice led us to identify previously undetected neuronal loss in CA1, CA3, and dentate gyrus, as well as hippocampal-dependent cognitive deficits.</AbstractText><AbstractText Label="CONCLUSIONS">Our data indicate that a loss of the repressive mark H3K9me3 in astrocytes and neurons in the central nervous system of C9BAC mice represents a signature during neurodegeneration and memory deficit of C9ALS/FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jury</LastName><ForeName>Nur</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abarzua</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FONDAP Center for Genome Regulation, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra</LastName><ForeName>Miguel V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampuero</LastName><ForeName>Estibaliz</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Current address: Faculty of Health Sciences, Universidad Aut&#xf3;noma de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cubillos</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera-Soto</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arredondo</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manterola</LastName><ForeName>Marcia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Program of Human Genetics, ICBM, Faculty of Medicine, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto de Gen&#xe9;tica Humana, Pontificia Universidad Javeriana, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montecino</LastName><ForeName>Mart&#xed;n</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FONDAP Center for Genome Regulation, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela-Nallar</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile. lorena.varela@unab.cl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Zundert</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4129-9972</Identifier><AffiliationInfo><Affiliation>Institute of Biomedical Sciences (ICB), Faculty of Medicine &amp; Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile. bvanzundert@unab.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CARE Biomedical Research Center, Faculty of Biological Sciences, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile. bvanzundert@unab.cl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Epigenetics</MedlineTA><NlmUniqueID>101516977</NlmUniqueID><ISSNLinking>1868-7075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606498">C9orf72 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000626468">histone H3 trimethyl Lys4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Astrocyte</Keyword><Keyword MajorTopicYN="N">Brain</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">H3K9me3</Keyword><Keyword MajorTopicYN="N">Memory</Keyword><Keyword MajorTopicYN="N">Neuron</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32070418</ArticleId><ArticleId IdType="pmc">PMC7029485</ArticleId><ArticleId IdType="doi">10.1186/s13148-020-0816-9</ArticleId><ArticleId IdType="pii">10.1186/s13148-020-0816-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001;58(11):1803&#x2013;1809. doi: 10.1001/archneur.58.11.1803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.58.11.1803</ArticleId><ArticleId IdType="pubmed">11708987</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4(11):771&#x2013;780. doi: 10.1016/S1474-4422(05)70223-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70223-4</ArticleId><ArticleId IdType="pubmed">16239184</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T, van der Zee J, Van Broeckhoven C. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med. 2012;44(8):817&#x2013;828. doi: 10.3109/07853890.2012.665471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2012.665471</ArticleId><ArticleId IdType="pmc">PMC3529157</ArticleId><ArticleId IdType="pubmed">22420316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama JS, Sirkis DW, Miller BL. C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity. Am J Neurodegener Dis. 2014;3(1):1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3986607</ArticleId><ArticleId IdType="pubmed">24753999</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126(6):829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84(6):1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016;90(3):535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Muhammad AKMG, Gendron TF, Kim KJ, Austin A, et al. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron. 2015;88(5):892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Cabrera GT, Tran H, Gendron TF, McKeon JE, Metterville J, et al. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice. Neuron. 2015;88(5):902&#x2013;909. doi: 10.1016/j.neuron.2015.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, et al. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron. 2016;90(3):521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K, et al. Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly (PR) toxicity. Science. 2019;363(6428).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80(2):415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A. 2013;110(47):E4530&#x2013;E4539. doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O'Rourke JG, Meera P, Muhammad AK, Grant S, Simpkinson M, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5(208):208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18(8):1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Saksouk N, Simboeck E, D&#xe9;jardin J. Constitutive heterochromatin formation and transcription in mammals. Epigenetics Chromatin. 2015;8:3. doi: 10.1186/1756-8935-8-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-8935-8-3</ArticleId><ArticleId IdType="pmc">PMC4363358</ArticleId><ArticleId IdType="pubmed">25788984</ArticleId></ArticleIdList></Reference><Reference><Citation>Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17(8):487&#x2013;500. doi: 10.1038/nrg.2016.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2016.59</ArticleId><ArticleId IdType="pubmed">27346641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller P, Gasser SM. The Importance of Satellite Sequence Repression for Genome Stability. Cold Spring Harb Symp Quant Biol. 2017;82:15&#x2013;24. doi: 10.1101/sqb.2017.82.033662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2017.82.033662</ArticleId><ArticleId IdType="pubmed">29133300</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojer P, Reinberg D. Facultative heterochromatin: is there a distinctive molecular signature? Mol Cell. 2007;28(1):1&#x2013;13. doi: 10.1016/j.molcel.2007.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.09.011</ArticleId><ArticleId IdType="pubmed">17936700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381&#x2013;395. doi: 10.1038/cr.2011.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.22</ArticleId><ArticleId IdType="pmc">PMC3193420</ArticleId><ArticleId IdType="pubmed">21321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Politz JC, Ragoczy T, Groudine M. When untethered, something silent inside comes. Nucleus. 2013;4(3):153&#x2013;155. doi: 10.4161/nucl.24999.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/nucl.24999</ArticleId><ArticleId IdType="pmc">PMC3720743</ArticleId><ArticleId IdType="pubmed">23714733</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansuroglu Z, Benhelli-Mokrani H, Marcato V, Sultan A, Violet M, Chauderlier A, et al. Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin. Sci Rep. 2016;6:33047. doi: 10.1038/srep33047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33047</ArticleId><ArticleId IdType="pmc">PMC5015075</ArticleId><ArticleId IdType="pubmed">27605042</ArticleId></ArticleIdList></Reference><Reference><Citation>Harr JC, Gonzalez-Sandoval A, Gasser SM. Histones and histone modifications in perinuclear chromatin anchoring: from yeast to man. EMBO Rep. 2016;17(2):139&#x2013;155. doi: 10.15252/embr.201541809.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541809</ArticleId><ArticleId IdType="pmc">PMC4783997</ArticleId><ArticleId IdType="pubmed">26792937</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Hemberg M, Lewis J, Feany MB. Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci. 2014;17(3):357&#x2013;366. doi: 10.1038/nn.3639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3639</ArticleId><ArticleId IdType="pmc">PMC4012297</ArticleId><ArticleId IdType="pubmed">24464041</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Ortega K, Garcia-Esparcia P, Gil L, Lucas JJ, Ferrer I. Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome. Brain Pathol. 2016;26(5):593&#x2013;605. doi: 10.1111/bpa.12335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12335</ArticleId><ArticleId IdType="pubmed">26512942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Liu A, Wang ZJ, Cao Q, Wang W, Lin L, et al. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease. Brain. 2019;142(3):787&#x2013;807. doi: 10.1093/brain/awy354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy354</ArticleId><ArticleId IdType="pmc">PMC6391616</ArticleId><ArticleId IdType="pubmed">30668640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci U S A. 2006;103(50):19176&#x2013;19181. doi: 10.1073/pnas.0606373103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606373103</ArticleId><ArticleId IdType="pmc">PMC1748195</ArticleId><ArticleId IdType="pubmed">17142323</ArticleId></ArticleIdList></Reference><Reference><Citation>Linhoff MW, Garg SK, Mandel G. A high-resolution imaging approach to investigate chromatin architecture in complex tissues. Cell. 2015;163(1):246&#x2013;255. doi: 10.1016/j.cell.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.002</ArticleId><ArticleId IdType="pmc">PMC4583660</ArticleId><ArticleId IdType="pubmed">26406379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz E, Izaurieta P, Weiss A, Mir FR, Rojas P, Gonzalez D, et al. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J Neurophysiol. 2013;109(11):2803&#x2013;2814. doi: 10.1152/jn.00500.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00500.2012</ArticleId><ArticleId IdType="pmc">PMC3680799</ArticleId><ArticleId IdType="pubmed">23486205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front Cell Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81(5):1001&#x2013;1008. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A, Myszczynska MA, Castelli LM, O'Neill B, Kim Y, Talbot J, et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. EBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Espana-Agusti J, Warren A, Chew SK, Adams DJ, Matakidou A. Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis. Nat Commun. 2017;8(1):2026. doi: 10.1038/s41467-017-02245-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02245-1</ArticleId><ArticleId IdType="pmc">PMC5725450</ArticleId><ArticleId IdType="pubmed">29229903</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Sun L, Wang K, Wu D, Trappio M, Witting C, et al. Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome. PLoS One. 2016;11(12):e0167454. doi: 10.1371/journal.pone.0167454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167454</ArticleId><ArticleId IdType="pmc">PMC5131972</ArticleId><ArticleId IdType="pubmed">27907109</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitson TD, Holt SG, Tan SJ, Wigg B, Samuel CS, Smith ER. Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-&#x3b2;1 Stimulation. Front Pharmacol. 2017;8:307. doi: 10.3389/fphar.2017.00307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00307</ArticleId><ArticleId IdType="pmc">PMC5447091</ArticleId><ArticleId IdType="pubmed">28611663</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YM, Gao EE, Wang QQ, Tian H, Hou J. Effects of histone methyltransferase inhibitor chaetocin on histone H3K9 methylation of cultured ovine somatic cells and development of preimplantation cloned embryos. Reprod Toxicol. 2018;79:124&#x2013;131. doi: 10.1016/j.reprotox.2018.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reprotox.2018.06.006</ArticleId><ArticleId IdType="pubmed">29909068</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-Burgos L, et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell. 2003;12(6):1577&#x2013;1589. doi: 10.1016/S1097-2765(03)00477-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(03)00477-5</ArticleId><ArticleId IdType="pubmed">14690609</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Sch&#xf6;fer C, et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell. 2001;107(3):323&#x2013;337. doi: 10.1016/S0092-8674(01)00542-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00542-6</ArticleId><ArticleId IdType="pubmed">11701123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 2003;13(14):1192&#x2013;1200. doi: 10.1016/S0960-9822(03)00432-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(03)00432-9</ArticleId><ArticleId IdType="pubmed">12867029</ArticleId></ArticleIdList></Reference><Reference><Citation>Poleshko A, Smith CL, Nguyen SC, Sivaramakrishnan P, Wong KG, Murray JI, et al. H3K9me2 orchestrates inheritance of spatial positioning of peripheral heterochromatin through mitosis. Elife. 2019;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6795522</ArticleId><ArticleId IdType="pubmed">31573510</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Yao JF, Huang RF, Zheng FF, Jiang XH, Chen X, et al. Effect of BIX-01294 on H3K9me2 levels and the imprinted gene Snrpn in mouse embryonic fibroblast cells. Biosci Rep. 2015;35(5):e00257. doi: 10.1042/BSR20150064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20150064</ArticleId><ArticleId IdType="pmc">PMC4613706</ArticleId><ArticleId IdType="pubmed">26285804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarte F, Sousae R, Cinquin B, Martin EW, Krietsch J, Sanchez G, et al. Progressive Chromatin Condensation and H3K9 Methylation Regulate the Differentiation of Embryonic and Hematopoietic Stem Cells. Stem Cell Reports. 2015;5(5):728&#x2013;740. doi: 10.1016/j.stemcr.2015.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.09.009</ArticleId><ArticleId IdType="pmc">PMC4649257</ArticleId><ArticleId IdType="pubmed">26489895</ArticleId></ArticleIdList></Reference><Reference><Citation>Terranova R, Sauer S, Merkenschlager M, Fisher AG. The reorganisation of constitutive heterochromatin in differentiating muscle requires HDAC activity. Exp Cell Res. 2005;310(2):344&#x2013;356. doi: 10.1016/j.yexcr.2005.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2005.07.031</ArticleId><ArticleId IdType="pubmed">16182285</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel-Ciernia A, Wood MA. Examining object location and object recognition memory in mice. Curr Protoc Neurosci. 2014;69:8.31.1&#x2013;8.3117. doi: 10.1002/0471142301.ns0831s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142301.ns0831s69</ArticleId><ArticleId IdType="pmc">PMC4219523</ArticleId><ArticleId IdType="pubmed">25297693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustos FJ, Ampuero E, Jury N, Aguilar R, Falahi F, Toledo J, et al. Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer's disease mice. Brain. 2017;140(12):3252&#x2013;3268. doi: 10.1093/brain/awx272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx272</ArticleId><ArticleId IdType="pmc">PMC5841035</ArticleId><ArticleId IdType="pubmed">29155979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, Rothstein JD. C9ORF72-ALS/FTD: Transgenic Mice Make a Come-BAC. Neuron. 2016;90(3):427&#x2013;431. doi: 10.1016/j.neuron.2016.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.026</ArticleId><ArticleId IdType="pmc">PMC7045171</ArticleId><ArticleId IdType="pubmed">27151634</ArticleId></ArticleIdList></Reference><Reference><Citation>Masala A, Sanna S, Esposito S, Rassu M, Galioto M, Zinellu A, Carru C, Carr&#xec; MT, Iaccarino C, Crosio C. Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes. Neuroscience. 2018;390:1&#x2013;11. doi: 10.1016/j.neuroscience.2018.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.08.009</ArticleId><ArticleId IdType="pubmed">30134203</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R, Cabrera GT, Andrade NS, Gendron TF, Brown RH, Jr, Benatar M, et al. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD. Mol Neurodegener. 2017;12(1):46. doi: 10.1186/s13024-017-0185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0185-9</ArticleId><ArticleId IdType="pmc">PMC5468954</ArticleId><ArticleId IdType="pubmed">28606110</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126(6):895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Gendron TF, Murray ME, Dickson D, Petrucelli L. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 2014;1584:15&#x2013;21. doi: 10.1016/j.brainres.2014.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.02.015</ArticleId><ArticleId IdType="pmc">PMC4130919</ArticleId><ArticleId IdType="pubmed">24530272</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Katzman RB, Petrucelli L. ALS and FTD: an epigenetic perspective. Acta Neuropathol. 2016;132(4):487&#x2013;502. doi: 10.1007/s00401-016-1587-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1587-4</ArticleId><ArticleId IdType="pmc">PMC5138862</ArticleId><ArticleId IdType="pubmed">27282474</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, Yunusova Y, van Blitterswijk M, Dib S, Ghani M, Moreno D, et al. Identical twins with the C9orf72 repeat expansion are discordant for ALS. Neurology. 2014;83(16):1476&#x2013;1478. doi: 10.1212/WNL.0000000000000886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000886</ArticleId><ArticleId IdType="pmc">PMC4206161</ArticleId><ArticleId IdType="pubmed">25209579</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, Russ J, Wu K, Neal D, Suh E, McNally AG, et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. 2014;128(4):525&#x2013;541. doi: 10.1007/s00401-014-1286-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1286-y</ArticleId><ArticleId IdType="pmc">PMC4161616</ArticleId><ArticleId IdType="pubmed">24806409</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan CT, Russ J, Wood EM, Irwin DJ, Grossman M, McCluskey L, et al. C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology. 2015;84(16):1622&#x2013;1630. doi: 10.1212/WNL.0000000000001495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001495</ArticleId><ArticleId IdType="pmc">PMC4409587</ArticleId><ArticleId IdType="pubmed">25795648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature. 2001;410(6824):120&#x2013;124. doi: 10.1038/35065138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35065138</ArticleId><ArticleId IdType="pubmed">11242054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 2001;410(6824):116&#x2013;120. doi: 10.1038/35065132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35065132</ArticleId><ArticleId IdType="pubmed">11242053</ArticleId></ArticleIdList></Reference><Reference><Citation>Regha K, Sloane MA, Huang R, Pauler FM, Warczok KE, Melikant B, et al. Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. Mol Cell. 2007;27(3):353&#x2013;366. doi: 10.1016/j.molcel.2007.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.06.024</ArticleId><ArticleId IdType="pmc">PMC2847180</ArticleId><ArticleId IdType="pubmed">17679087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller P, Padeken J, van Schendel R, Kalck V, Tijsterman M, Gasser SM. Histone H3K9 methylation is dispensable for Caenorhabditis elegans development but suppresses RNA:DNA hybrid-associated repeat instability. Nat Genet. 2016;48(11):1385&#x2013;1395. doi: 10.1038/ng.3672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3672</ArticleId><ArticleId IdType="pubmed">27668659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijchers PJ, Geeven G, Eyres M, Bergsma AJ, Janssen M, Verstegen M, et al. Characterization and dynamics of pericentromere-associated domains in mice. Genome Res. 2015;25(7):958&#x2013;969. doi: 10.1101/gr.186643.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.186643.114</ArticleId><ArticleId IdType="pmc">PMC4484393</ArticleId><ArticleId IdType="pubmed">25883320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Samimi H, Gamez M, Zare H, Frost B. Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci. 2018;21(8):1038&#x2013;1048. doi: 10.1038/s41593-018-0194-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0194-1</ArticleId><ArticleId IdType="pmc">PMC6095477</ArticleId><ArticleId IdType="pubmed">30038280</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F, Gonzalez D, Cortes N, Ampuero E, Hern&#xe1;ndez DE, Fritz E, et al. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front Cell Neurosci. 2015;9:203. doi: 10.3389/fncel.2015.00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00203</ArticleId><ArticleId IdType="pmc">PMC4460879</ArticleId><ArticleId IdType="pubmed">26106294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakata H. Morphology of mouse seminiferous tubules. Anat Sci Int. 2019;94(1):1&#x2013;10. doi: 10.1007/s12565-018-0455-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12565-018-0455-9</ArticleId><ArticleId IdType="pubmed">30128978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>